MedPath

A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease

Not Applicable
Conditions
Hand, Foot and Mouth Disease
Interventions
Drug: Western therapy
Drug: Herbal concentrate-granules plus western therapy
Drug: Reduning Injection plus western therapy
Registration Number
NCT01145664
Lead Sponsor
Beijing YouAn Hospital
Brief Summary

The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe hand-foot-mouth disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
390
Inclusion Criteria
  1. Clinical diagnosis of severe hand-foot-mouth disease patients according to hand-foot-mouth disease treatment guidelines 2010 issued by China's Ministry of Health
  2. not more than 24 hours of occurrence of severe symptoms
  3. age of 1-13 years
  4. Patients or their guardians agree to participate in this study and signed the informed consent form
Exclusion Criteria
  1. Suffering from neurogenic pulmonary edema, heart or lung failure.
  2. Complicated with other serious diseases such as chronic hepatitis, congenital heart disease, acute or chronic nephritis and blood diseases, etc
  3. the history of allergies on Chinese medicine
  4. the history of mild increase of blood bilirubin hemolysis (or uric bravery former positive) phenomenon
  5. using hormonal therapy
  6. Attending other clinical studies on hand-foot-mouth disease
  7. Patients or their guardians suffering from mental illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Western therapyWestern therapy-
Herbal concentrate-granules plus western therapyHerbal concentrate-granules plus western therapy-
Reduning Injection plus western therapyReduning Injection plus western therapy-
Primary Outcome Measures
NameTimeMethod
incidence of complications15 days
incidence of critically ill patients15 days
Secondary Outcome Measures
NameTimeMethod
case fatality rate15 days
time of symptom disappearance15 days
time of bringing down a fever15 days
length of stay15 days
dose and usage of hormones15 days
safety outcome(adverse effects)15 days

Trial Locations

Locations (6)

Guangzhou Women and Children Hospital

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangxi Medical University

🇨🇳

Nanning, Guangxi, China

Kaifeng Municipal Children's Hospital

🇨🇳

Kaifeng, Henan, China

Hunan Provincial Children's Hospital

🇨🇳

Changsha, Hunan, China

Anhui Provincial Children's Hospital

🇨🇳

Anhui, China

Beijing YouAn Hospital,Capital Medical University

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath